Enhancing the indicator for COVID-19 confirmed cases

  • Masoud Ferdosi ORCID Health Management and Economics Research Center, Isfahan University of Medical Sciences, School of Management and Medical Information, Isfahan, Iran
  • Ehsan Mostafavi ORCID Mail Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran
COVID-19;, Coronavirus;, Indicator


No abstract No abstract No abstract


1. WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 March 2020. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---16-march-2020.
2. Novel Coronavirus (2019-nCoV) Situation Report – 8. Available at: https://apps.who.int/iris/bitstream/handle/10665/330773/nCoVsitrep28Jan2020-eng.pdf?sequence=1&isAllowed=y
3. Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. J Infect 2020; 80:388-393.
4. Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19—studies needed. N Engl J Med 2020;382:1194-1196.
5. Ozma MA, Maroufi P, Khodadadi E, Köse Ş, Esposito I, Ganbarov K, et al. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med 2020;28:153-165.
6. Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 2020; 20:656-657.
How to Cite
Ferdosi M, Mostafavi E. Enhancing the indicator for COVID-19 confirmed cases. Iran J Microbiol. 12(6):505-507.
Invited Commentary